Search

Your search keyword '"Eva M. Vasquez"' showing total 26 results

Search Constraints

Start Over You searched for: Author "Eva M. Vasquez" Remove constraint Author: "Eva M. Vasquez"
26 results on '"Eva M. Vasquez"'

Search Results

1. Effects of oral clotrimazole troches on the pharmacokinetics of oral and intravenous midazolam

2. Impact of mycophenolate mofetil on recurrent rejection in kidney transplant patients

3. Transplant pharmacists’ opinions on generic product selection of critical-dose drugs

4. THE PHARMACOKINETICS OF A MICROEMULSION FORMULATION OF CYCLOSPORINE IN PRIMARY RENAL ALLOGRAFT RECIPIENTS1

5. Clinically significant drug interaction between basiliximab and tacrolimus in renal transplant recipients

6. SAFETY AND TOLERABILITY OF CYCLOSPORINE MICROEMULSION VERSUS CYCLOSPORINE: TWO-YEAR DATA IN PRIMARY RENAL ALLOGRAFT RECIPIENTS

7. Concomitant clotrimazole therapy more than doubles the relative oral bioavailability of tacrolimus

8. An assessment of P-glycoprotein expression and activity in peripheral blood lymphocytes of transplant candidates

9. EFFECT OF PRETRANSPLANT ERYTHROPOIETIN THERAPY ON RENAL ALLOGRAFT OUTCOME

10. THE SAFETY AND TOLERABILITY OF CYCLOSPORINE EMULSION VERSUS CYCLOSPORINE IN A RANDOMIZED, DOUBLE-BLIND COMPARISON IN PRIMARY RENAL ALLOGRAFT RECIPIENTS1

11. Medication noncompliance after kidney transplantation

12. Ethnic differences in clinical response to corticosteroid treatment of acute renal allograft rejection

13. Late acute rejection is more prevalent among African-American renal allograft recipients and is frequently associated with allograft loss

14. Value of perioperative treatment with sandostatin after pancreas transplantation: a prospective randomized trial

15. A prospective randomized clinical trial of perioperative treatment with octreotide in pancreas transplantation

16. The impact of quadruple immunosuppression with OKT3 on kidney transplantation in black recipients

20. HIGH-DOSE ORAL ACYCLOVIR PROPHYLAXIS FOR PRIMARY CYTOMEGALOVIRUS INFECTION IN SERONEGATIVE RENAL ALLOGRAFT RECIPIENTS

25. Clinically Significant Hearing Loss in Renal Allograft Recipients Treated With Intravenous Erythromycin

Catalog

Books, media, physical & digital resources